MedPath

Clinical study of Wenyang Tongluo prescription combined with minimally invasive external therapy in the treatment of plasma cell mastitis

Not Applicable
Conditions
Plasma cell mastitis
Registration Number
ITMCTR2000003681
Lead Sponsor
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

1. It meets the PCM diagnostic criteria and is confirmed by pathology;
2. The patient is female;
3. Aged 18-70 years;
4. Agree to participate in the clinical trial and sign the informed consent.

Exclusion Criteria

1. Pregnant or lactating women;
2. Can't tolerate traditional Chinese medicine or have allergic reactions to traditional Chinese medicine;
3. Patients with severe hyperthyroidism, diabetes, cardiovascular and cerebrovascular diseases, malignant tumors and mental diseases;
4. Unable to cooperate with the research for any reason, such as the following: language understanding, unable to go to the research center, etc.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Rate of surgery;Treatment cycle;Cost of treatment;Recovery rate;Contour scar area;The recurrence rate;
Secondary Outcome Measures
NameTimeMethod
The type of survey;Health assessment;Serum immunological index;Safety index;
© Copyright 2025. All Rights Reserved by MedPath